These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Pharmacists' role in the post-discharge management of patients with heart failure: a literature review. Ponniah A; Anderson B; Shakib S; Doecke CJ; Angley M J Clin Pharm Ther; 2007 Aug; 32(4):343-52. PubMed ID: 17635336 [TBL] [Abstract][Full Text] [Related]
5. Boost outcomes--add a clinical pharmacist to the team. Clin Resour Manag; 2001 Jan; 2(1):6-10, 1. PubMed ID: 11215356 [TBL] [Abstract][Full Text] [Related]
6. Pharmacist's contribution in a heart function clinic: patient perception and medication appropriateness. Bucci C; Jackevicius C; McFarlane K; Liu P Can J Cardiol; 2003 Mar; 19(4):391-6. PubMed ID: 12704485 [TBL] [Abstract][Full Text] [Related]
7. Population-based effort takes promise of DM to a new level with CAD patients. Dis Manag Advis; 2002 Feb; 8(2):21-4, 17. PubMed ID: 11910956 [TBL] [Abstract][Full Text] [Related]
12. Predictive modeling care management program produces dramatic bottom line results. Dis Manag Advis; 2001 May; 7(5):71-4. PubMed ID: 11398277 [TBL] [Abstract][Full Text] [Related]
13. Impact of a comprehensive telephone-based disease management programme on quality-of-life in patients with heart failure. Ramachandran K; Husain N; Maikhuri R; Seth S; Vij A; Kumar M; Srivastava N; Prabhakaran D; Airan B; Reddy KS Natl Med J India; 2007; 20(2):67-73. PubMed ID: 17802984 [TBL] [Abstract][Full Text] [Related]
14. Provision of risk management and risk assessment information: the role of the pharmacist. Schommer JC; Pedersen CA; Worley MM; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL; Chewning BA Res Social Adm Pharm; 2006 Dec; 2(4):458-78. PubMed ID: 17161806 [TBL] [Abstract][Full Text] [Related]
15. Boost outcomes by adding a clinical pharmacist to the disease management team. Healthc Demand Dis Manag; 2000 Jun; 6(6):85-8. PubMed ID: 11066298 [TBL] [Abstract][Full Text] [Related]
16. A taxonomy for disease management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Krumholz HM; Currie PM; Riegel B; Phillips CO; Peterson ED; Smith R; Yancy CW; Faxon DP; Circulation; 2006 Sep; 114(13):1432-45. PubMed ID: 16952985 [TBL] [Abstract][Full Text] [Related]
17. Procedures and methods of benefit assessments for medicines in Germany. Bekkering GE; Kleijnen J Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905 [TBL] [Abstract][Full Text] [Related]